stockportfolio.pro
NeoGenomics, Inc. Total Debt 2010–2025
NeoGenomics, Inc. (NEO) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $341.86M | -36.8% |
| FY 2024 | $541.11M | +0.5% |
| FY 2023 | $538.20M | — |
| FY 2022 | $0 | — |
| FY 2021 | $0 | — |
| FY 2020 | $0 | — |
| FY 2019 | $0 | -100.0% |
| FY 2018 | $101.75M | +5.3% |
| FY 2017 | $96.65M | -1.3% |
| FY 2016 | $97.90M | +77.9% |
| FY 2015 | $55.02M | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | — |
| FY 2010 | $0 | — |
Source: NeoGenomics, Inc. SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for NeoGenomics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeNeoGenomics, Inc. — frequently asked questions
What is NeoGenomics, Inc.'s total debt (short- plus long-term borrowings)?
NeoGenomics, Inc. (NEO) reported total debt (short- plus long-term borrowings) of $341.86M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from NeoGenomics, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.